Ignite Creation Date:
2024-05-06 @ 3:26 PM
Last Modification Date:
2024-10-26 @ 1:49 PM
Study NCT ID:
NCT04633902
Status:
RECRUITING
Last Update Posted:
2022-12-06
First Post:
2020-11-12
Brief Title:
Phase II Study of Olaparib and Pembrolizumab in Advanced Melanoma With Homologous Recombination HR Mutation
Sponsor:
California Pacific Medical Center Research Institute
Organization:
California Pacific Medical Center Research Institute
Organization Data
Organization:
California Pacific Medical Center Research Institute
Class:
OTHER
Study ID:
CPMC19-MEL01
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
California Pacific Medical Center Research Institute
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| MD Anderson Cancer Center | OTHER |